338 Emerging insights on the association of tumor molecular phenotype with clinical benefit in metastatic colorectal cancer (mCRC) subjects treated with AB928 + modified FOLFOX-6 (mFOLFOX-6)

• Matthew Walters,
• Stephen Young,
• Michael Cecchini,
• Houston Gilbert,
• Akshata Udyavar,
• Daniel DiRenzo,
• Sean Cho,
• Lisa Seitz,
• Kristen Zhang,
• Amy Anderson,
• Kimberline Gerrick,
• Olivia Gardner,
• Cheng Quah,
• Juan Jaen,
• William Grossman

Affiliations

Matthew Walters

1Arcus Biosciences Inc, Hayward, CA, USA

Stephen Young

1Arcus Biosciences Inc, Hayward, CA, USA

Michael Cecchini

2Yale University, New Haven, CT, USA

Houston Gilbert

1Arcus Biosciences Inc, Hayward, CA, USA

Akshata Udyavar

1Arcus Biosciences Inc, Hayward, CA, USA

Daniel DiRenzo

1Arcus Biosciences Inc, Hayward, CA, USA

Sean Cho

1Arcus Biosciences Inc, Hayward, CA, USA

Lisa Seitz

1Arcus Biosciences Inc, Hayward, CA, USA

Kristen Zhang

1Arcus Biosciences Inc, Hayward, CA, USA

Amy Anderson

1Arcus Biosciences Inc, Hayward, CA, USA

Kimberline Gerrick

1Arcus Biosciences Inc, Hayward, CA, USA

Olivia Gardner

1Arcus Biosciences Inc, Hayward, CA, USA

Cheng Quah

1Arcus Biosciences Inc, Hayward, CA, USA

Juan Jaen

1Arcus Biosciences Inc, Hayward, CA, USA

William Grossman

1Arcus Biosciences Inc, Hayward, CA, USA